399 related articles for article (PubMed ID: 34357885)
1. Exercise Is Medicine for Immune Function: Implication for COVID-19.
Nieman DC
Curr Sports Med Rep; 2021 Aug; 20(8):395-401. PubMed ID: 34357885
[TBL] [Abstract][Full Text] [Related]
2. Post-COVID-19 syndrome and type 2 diabetes: Primacy of exercise in prevention and management.
Jayasinghe S; Misra A; Hills AP
Diabetes Metab Syndr; 2022 Jan; 16(1):102379. PubMed ID: 34974328
[No Abstract] [Full Text] [Related]
3. Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
Lu L; Zhang H; Zhan M; Jiang J; Yin H; Dauphars DJ; Li SY; Li Y; He YW
Sci China Life Sci; 2020 Dec; 63(12):1833-1849. PubMed ID: 33355886
[TBL] [Abstract][Full Text] [Related]
4. Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control.
Salvamani S; Tan HZ; Thang WJ; Ter HC; Wan MS; Gunasekaran B; Rhodes A
Br J Biomed Sci; 2020 Oct; 77(4):168-184. PubMed ID: 32942955
[TBL] [Abstract][Full Text] [Related]
5. Systematic Review of Changes and Recovery in Physical Function and Fitness After Severe Acute Respiratory Syndrome-Related Coronavirus Infection: Implications for COVID-19 Rehabilitation.
Rooney S; Webster A; Paul L
Phys Ther; 2020 Sep; 100(10):1717-1729. PubMed ID: 32737507
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Therapeutic Exercise in Reversing Decreased Strength, Impaired Respiratory Function, Decreased Physical Fitness, and Decreased Quality of Life Caused by the Post-COVID-19 Syndrome.
Fernández-Lázaro D; Santamaría G; Sánchez-Serrano N; Lantarón Caeiro E; Seco-Calvo J
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560801
[TBL] [Abstract][Full Text] [Related]
7. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 vaccines for patients with haematological conditions.
Sun C; Pleyer C; Wiestner A
Lancet Haematol; 2021 May; 8(5):e312-e314. PubMed ID: 33811822
[No Abstract] [Full Text] [Related]
9. [The value of COVID-19 vaccination in the context of Long-COVID].
Bauernfeind S; Schmidt B
Inn Med (Heidelb); 2022 Aug; 63(8):840-850. PubMed ID: 35925072
[TBL] [Abstract][Full Text] [Related]
10. Doctor-Should I get the COVID-19 vaccine? Infection and immunization in individuals with neuromuscular disorders.
Živković SA; Gruener G; Narayanaswami P;
Muscle Nerve; 2021 Mar; 63(3):294-303. PubMed ID: 33471383
[TBL] [Abstract][Full Text] [Related]
11. Physical Therapy Management of an Individual With Post-COVID Syndrome: A Case Report.
Mayer KP; Steele AK; Soper MK; Branton JD; Lusby ML; Kalema AG; Dupont-Versteegden EE; Montgomery-Yates AA
Phys Ther; 2021 Jun; 101(6):. PubMed ID: 33735380
[TBL] [Abstract][Full Text] [Related]
12. [Update 2021: COVID-19 from the perspective of infectious diseases specialty].
Khatamzas E; Kroidl I
Dtsch Med Wochenschr; 2021 Jul; 146(13-14):904-907. PubMed ID: 34256405
[TBL] [Abstract][Full Text] [Related]
13. Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need.
Jin P; Li J; Pan H; Wu Y; Zhu F
Signal Transduct Target Ther; 2021 Feb; 6(1):48. PubMed ID: 33531462
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL
Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768
[TBL] [Abstract][Full Text] [Related]
15. Symptoms After COVID-19 Vaccination in Patients With Persistent Symptoms After Acute Infection: A Case Series.
Arnold DT; Milne A; Samms E; Stadon L; Maskell NA; Hamilton FW
Ann Intern Med; 2021 Sep; 174(9):1334-1336. PubMed ID: 34029484
[No Abstract] [Full Text] [Related]
16. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccines: what do we know so far?
Dhillon P; Altmann D; Male V
FEBS J; 2021 Sep; 288(17):4996-5009. PubMed ID: 34288409
[TBL] [Abstract][Full Text] [Related]
18. An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination.
Khade SM; Yabaji SM; Srivastava J
Prep Biochem Biotechnol; 2021; 51(7):650-658. PubMed ID: 33226885
[TBL] [Abstract][Full Text] [Related]
19. Potential SARS-CoV-2 vaccines: Concept, progress, and challenges.
Hosseini SA; Zahedipour F; Mirzaei H; Kazemi Oskuee R
Int Immunopharmacol; 2021 Aug; 97():107622. PubMed ID: 33895475
[TBL] [Abstract][Full Text] [Related]
20. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.
Amit S; Regev-Yochay G; Afek A; Kreiss Y; Leshem E
Lancet; 2021 Mar; 397(10277):875-877. PubMed ID: 33610193
[No Abstract] [Full Text] [Related]
[Next] [New Search]
